Clinical trial
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
NCT02700776 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Observational
- Overall status
- Terminated
- Start date
- April 30, 2014
- Completion date
- February 27, 2017
- Enrollment
- 417 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers